IRCT20090117001556N128招募中2 期
Sulforaphane as a treatment for mild to moderate depression in post percutaneous coronary intervention patients: A randomized double blind and placebo controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 65 years（—）
- 性别
- All
入选标准
- •Based on DSM-5 diagnostic criteria, have minor depression disorder
- •Based on Hamilton depression scale, get the score of 14 to 17
- •Age between 40 to 65 years
- •History of percutaneous coronary intervention
排除标准
- •Pregnant or lactating women
- •Presence of other psychiatric disorders
- •Be psychotic
- •History of Electroconvulsive therapy, two months prior to the trial
- •Using psychotropic drug
- •Drug addiction
- •Presence of Thyroid disease
研究者
相似试验
已完成
2 期
Saffron and AlzheimerIRCT138711051556N1Tehran University of Medical Sciences50
招募中
2 期
Sulforaphane for the treatment of ADHDIRCT20090117001556N146Tehran University of Medical Sciences50
已完成
3 期
Saffron in the treatment of OCDL a randomisedObsessive-compulsive disorderObsessive- Cumpulsive Disorder.IRCT201407151556N62Tehran University of Medical Sciences50
撤回
2 期
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer ChemopreventionUrothelial CarcinomaBladder CancerBladder TumorNCT03517995H. Lee Moffitt Cancer Center and Research Institute
招募中
2 期
The effect of sulforaphane on depression in women with PCOSSeverity of depression.Polycystic ovarian syndromeE28.2IRCT20090117001556N144Tehran University of Medical Sciences50